Pancreatic Cancer

• Pancreatic cancer
• Irreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: A pr...
• Preoperative neutrophil‐to‐lymphocyte ratio (NLR) predicts recurrence after surgery in patient with pancreatic neuroendocrine neoplasm (PanNEN)
• Clinical outcomes of second-line chemotherapy after progression on nab-paclitaxel plus gemcitabine in patients with metastatic pancreatic adenocarc...
• Evaluation of the effect of cholesorption on the concentration of TNF-α in the serum of the blood in tumours of the biliopancreatoduodenal zone
• Genetic characteristics of participants in the Australian Pancreatic Screening Study
• The emerging role of third-line gemcitabine plus nab-paclitaxel in advanced pancreatic adenocarcinoma
• Durable response to second-line m-FOLFIRINOX for advanced pancreatic adenocarcinoma in patients with performance status of two or less
• Liposomal irinotecan (nal-IRI) plus 5-fluorouracil/levoleucovorin (5 FU/LV) vs 5-FU/LV in Japanese patients (pts) with gemcitabine-refractory metas...
• Prognostic usefulness of advanced lung cancer inflammation index in locally-advanced pancreatic carcinoma patients treated with radical chemoradiot...
• Pancreaticoduodenectomy versus combined neoadjuvant chemotherapy and pancreaticoduodenectomy: Survival patterns among patients with stage II & III...
• HGCSG1601: A retrospective cohort study of the efficacy and safety of nab-paclitaxel plus gemcitabine (nab-P+GEM) for unresectable locally advanced...
• Prognostic impact of the C-reactive protein/albumin ratio in advanced pancreatic cancer treated with GEM plus nab-PTX or FOLFIRINOX: Based on the r...
• Details of response with first-line gemcitabine and nab-paclitaxel therapy in patients with advanced pancreatic cancer
• Clinical importance of the determination of interleukin-6 in bile and blood in tumours of biliopancreatoduodenal zone
• Real-world fusion landscape in advanced Chinese pancreatic cancer using next generation sequecing: A multicenter study
• Whole-exome sequencing of tumour-only samples reveals the association between somatic alterations and clinical features in pancreatic cancer
• Screening of prognostic molecular biomarker for resectable pancreatic cancer
• Postoperative metastasis prediction based on portal vein circulating tumor cells detected by flow cytometry in periampullary or pancreatic cancer
• Olaparib as maintenance treatment following first-line platinum-based chemotherapy (PBC) in patients (pts) with a germline BRCA mutation and metast...
• What’s new in metastatic pancreatic cancer management?
• Expert Opinion on ‘PARP inhibitors as targeted therapy for personalized medicine’ - Panel Discussion
• Plasma ctDNA RAS mutation analysis by digital polymerase chain reaction in patients with inoperable pancreatic cancer
• Exploring the role of the DDB2 protein as a potent molecular target in pancreatic ductal adenocarcinoma
• Not only gene mutation matters: Development of flow cytometry panel to determine BRCA2 deficiency for personalised therapy by PARP inhibitors in pa...

• « Previous
• 1
• 2
• ...
• 19
• Next »